Ryan Specialty Holdings, Inc. (RYAN)
| Market Cap | 10.72B -26.1% |
| Revenue (ttm) | 3.16B +14.8% |
| Net Income | 99.03M +77.9% |
| EPS | 0.73 |
| Shares Out | 255.81M |
| PE Ratio | 57.50 |
| Forward PE | 18.30 |
| Dividend | $0.52 (1.24%) |
| Ex-Dividend Date | Aug 11, 2026 |
| Volume | 1,099,503 |
| Open | 41.89 |
| Previous Close | 41.91 |
| Day's Range | 41.19 - 42.21 |
| 52-Week Range | 29.28 - 59.19 |
| Beta | 0.56 |
| Analysts | Buy |
| Price Target | 50.84 (+21.31%) |
| Earnings Date | Jul 30, 2026 |
About RYAN
Ryan Specialty Holdings, Inc. operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, rest of Europe, India, Singapore, and internationally. The company offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter or a program administrator with delegated authority from insurance carriers. It serves commercial, industrial, institutional, indivi... [Read more]
Financial Performance
In 2025, Ryan Specialty Holdings's revenue was $2.99 billion, an increase of 21.95% compared to the previous year's $2.46 billion. Earnings were $63.40 million, a decrease of -33.03%.
Financial StatementsAnalyst Summary
According to 18 analysts, the average rating for RYAN stock is "Buy." The 12-month stock price target is $50.84, which is an increase of 21.31% from the latest price.
News
Ryan Specialty price target raised to $50 from $48 at Morgan Stanley
Morgan Stanley analyst Bob Huang raised the firm’s price target on Ryan Specialty (RYAN) to $50 from $48 and keeps an Overweight rating on the shares. The firm updated models…
Ryan Specialty price target raised to $55 from $50 at UBS
UBS raised the firm’s price target on Ryan Specialty (RYAN) to $55 from $50 and keeps a Buy rating on the shares.
Ryan Specialty price target raised to $48 from $42 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Ryan Specialty (RYAN) to $48 from $42 and keeps an Overweight rating on the shares.
Ryan Specialty price target raised to $45 from $39 at JPMorgan
JPMorgan raised the firm’s price target on Ryan Specialty (RYAN) to $45 from $39 and keeps an Underweight rating on the shares. The company reported a strong quarter but the…
Ryan Specialty price target raised to $53.50 from $50 at Citi
Citi raised the firm’s price target on Ryan Specialty (RYAN) to $53.50 from $50 and keeps a Buy rating on the shares.
Ryan Specialty price target raised to $55 from $45 at RBC Capital
RBC Capital raised the firm’s price target on Ryan Specialty (RYAN) to $55 from $45 and keeps an Outperform rating on the shares after its Q2 earnings beat. The firm…
Ryan Specialty price target raised to $48 from $44 at Piper Sandler
Piper Sandler raised the firm’s price target on Ryan Specialty (RYAN) to $48 from $44 and keeps a Neutral rating on the shares following quarterly results. The firm says that…
Ryan Specialty price target raised to $48 from $39 at Mizuho
Mizuho raised the firm’s price target on Ryan Specialty (RYAN) to $48 from $39 and keeps a Neutral rating on the shares.
Ryan Specialty price target raised to $45 from $40 at Goldman Sachs
Goldman Sachs analyst Robert Cox raised the firm’s price target on Ryan Specialty (RYAN) to $45 from $40 and keeps a Neutral rating on the shares. Investors are expected to…
Ryan Specialty price target raised to $54 from $48 at Keefe Bruyette
Keefe Bruyette raised the firm’s price target on Ryan Specialty (RYAN) to $54 from $48 and keeps an Outperform rating on the shares.
Ryan Specialty price target raised to $48 from $46 at Barclays
Barclays analyst Alex Scott raised the firm’s price target on Ryan Specialty (RYAN) to $48 from $46 and keeps an Overweight rating on the shares. The company beat Q2 organic…
Ryan Specialty Holdings Earnings Call Transcript: Q2 2026
Revenue grew 7.2% to $917M in Q2 2026, with strong organic growth and robust performance in casualty and professional lines. Adjusted EBITDA margin declined slightly, while EPS rose 12.1%. Guidance points to high-end mid-single digit organic growth for 2026 amid ongoing competition and pricing headwinds.
Ryan Specialty Holdings Earnings release: Q2 2026
Ryan Specialty Holdings released its Q2 2026 earnings on July 30, 2026, summarizing the period's financial results.
Ryan Specialty Holdings Quarterly report: Q2 2026
Ryan Specialty Holdings has published its Q2 2026 quarterly earnings report on July 30, 2026.
Ryan Specialty Holdings Slides: Q2 2026
Ryan Specialty Holdings has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 30, 2026.
Ryan Specialty affirms 2026 guidance for organic revenue growth
Ryan Specialty (RYAN) said, “The Company is maintaining its full year 2026 guidance for Organic Revenue Growth Rate and updating its full year 2026 guidance for Adjusted EBITDAC Margin as…
Ryan Specialty Reports Second Quarter 2026 Results
CHICAGO--(BUSINESS WIRE)--Ryan Specialty Holdings, Inc. (NYSE: RYAN) (“Ryan Specialty” or the “Company”), a leading international specialty insurance firm, today announced results for the second quart...
Ryan Specialty price target raised to $69 from $68 at BofA
BofA raised the firm’s price target on Ryan Specialty (RYAN) to $69 from $68 and keeps a Buy rating on the shares. Q2 featured several notable catastrophe events globally, including…
Ryan Specialty price target raised to $44 from $40 at Piper Sandler
Piper Sandler raised the firm’s price target on Ryan Specialty (RYAN) to $44 from $40 and keeps a Neutral rating on the shares. The firm adjusted ratings and target in…
Ryan Specialty price target raised to $39 from $37 at JPMorgan
JPMorgan raised the firm’s price target on Ryan Specialty (RYAN) to $39 from $37 and keeps an Underweight rating on the shares. The firm adjusted targets in the insurance broker…
Ryan Specialty price target raised to $34 from $33 at Cantor Fitzgerald
Cantor Fitzgerald raised the firm’s price target on Ryan Specialty (RYAN) to $34 from $33 and keeps a Neutral rating on the shares. The firm updated its model for the…
Ryan Specialty price target raised to $39 from $35 at Mizuho
Mizuho analyst Yaron Kinar raised the firm’s price target on Ryan Specialty (RYAN) to $39 from $35 and keeps a Neutral rating on the shares.
Ryan Specialty Underwriting Managers Completes a Series of Lloyd's Consortium Stamps to Support its Delegated Portfolio
CHICAGO--(BUSINESS WIRE)--Ryan Specialty Underwriting Managers (“RSUM”), the underwriting management division of Ryan Specialty (NYSE: RYAN), is pleased to announce the completion of a series of Lloyd...
Ryan Specialty to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026
CHICAGO--(BUSINESS WIRE)--Ryan Specialty Holdings, Inc. (NYSE: RYAN) (“Ryan Specialty”), a leading international specialty insurance firm, today announced it will release its Second Quarter 2026 finan...
RT Specialty Announces Planned Leadership Succession
CHICAGO--(BUSINESS WIRE)--Ryan Turner Specialty ("RT Specialty"), a leading wholesale distributor of specialty insurance products and services and the wholesale broking specialty of Ryan Specialty (NY...